Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track
Crossref DOI link: https://doi.org/10.1038/s41598-018-32309-1
Published Online: 2018-09-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
El-Wakeel, Sara A.
Rahmo, Rania M.
El-Abhar, Hanan S.
Text and Data Mining valid from 2018-09-25
Version of Record valid from 2018-09-25
Article History
Received: 1 May 2018
Accepted: 30 August 2018
First Online: 25 September 2018
Competing Interests
: The authors declare no competing interests.